VAERS reports by lot

GSK Varicella/Shingles lot XC534: VAERS reports

113 VAERS reports list lot XC534 as a GSK Varicella/Shingles vaccine, received between 2018-03-21 and 2021-09-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
113
Reports
10%
Marked serious
1
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)12327%
Injection-site / Local reaction10624%
Musculoskeletal4911%
Neurological4811%
Gastrointestinal358%
Dermatological (non-injection-site)307%
Cardiac / Cardiovascular266%
Allergic / Anaphylactic184%
Psychiatric / Neuropsychiatric82%
Respiratory41%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina10
Florida9
Pennsylvania9
New York8
Minnesota8
Texas6
Hawaii4
Arkansas4
Ohio4
Missouri3
Iowa3
Virginia3

Reports by month received

2018-038
2018-0447
2018-0533
2018-0612
2018-074
2018-082
2018-092
2018-102
2019-031
2019-071
2021-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.